Cannabist Company Holdings Inc - Asset Resilience Ratio
Cannabist Company Holdings Inc (CBST) has an Asset Resilience Ratio of 0.20% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CBST net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2023)
This chart shows how Cannabist Company Holdings Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CBST total asset value.
Liquid Assets Composition Over Time
This chart breaks down Cannabist Company Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore CBST strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$1.52 Million | 0.2% |
| Total Liquid Assets | CA$1.52 Million | 0.20% |
Asset Resilience Insights
- Limited Liquidity: Cannabist Company Holdings Inc maintains only 0.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Cannabist Company Holdings Inc Industry Peers by Asset Resilience Ratio
Compare Cannabist Company Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Piramal Pharma Limited
NSE:PPLPHARMA |
Drug Manufacturers - Specialty & Generic | 0.73% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
Annual Asset Resilience Ratio for Cannabist Company Holdings Inc (2020–2023)
The table below shows the annual Asset Resilience Ratio data for Cannabist Company Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.14% | CA$1.15 Million ≈ $830.45K |
CA$823.11 Million ≈ $595.43 Million |
-0.04pp |
| 2022-12-31 | 0.18% | CA$1.81 Million ≈ $1.31 Million |
CA$994.28 Million ≈ $719.24 Million |
-0.32pp |
| 2021-12-31 | 0.51% | CA$6.96 Million ≈ $5.03 Million |
CA$1.37 Billion ≈ $994.40 Million |
+0.30pp |
| 2020-12-31 | 0.21% | CA$1.51 Million ≈ $1.09 Million |
CA$727.53 Million ≈ $526.28 Million |
-- |
About Cannabist Company Holdings Inc
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Se… Read more